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formidable task can be daunting. The editor, Darwin
Eton, MD, has accomplished the task of creating a valu-
able handbook on vascular disease, with the added respon-
sibility of bringing together many specialists. Several
important changes have been made since the first edition,
which include reducing the dimensions of the book and
adding two more chapters on vascular stents and stent
grafts. The trade-off for keeping the handbook reasonably
priced and compact is a decrease in paper quality (glossy
white to plain white) and, unfortunately, the deletion of a
28-page color insert containing beautiful photographs of
color duplex scans and vascular pathology. Perhaps the
editor will reintroduce this into a third edition, if pub-
lished.
Unlike other handbooks specifically targeted to med-
ical students or surgical residents in early years of training,
this handbook describing a multi-specialty approach to
vascular disease will be useful to a wide range of physician
specialties. Family medicine, internal medicine, and emer-
gency medicine physicians may benefit from having this
handbook as a quick reference. In addition, the scope of
the book makes it a valuable source of information for res-
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Ischaemia-Reperfusion Injury is a comprehensive,
multiauthor review of both the clinical and experimental
aspects of ischaemia-reperfusion injury. The text is divided
into three sections entitled Clinical Features of Ischaemia-
Reperfusion Injury, Pathophysiology of Ischaemia-
Reperfusion Injury, and Treatment and Prophylaxis of
Ischaemia-Reperfusion Injury. The first section analyzes
the clinical significance of ischaemia-reperfusion injury on
an individual organ system basis and includes chapters
examining the systemic consequences, the systemic inflam-
matory response, and the relevance to transplantation.
The section focuses on those systems usually considered
susceptible to ischaemia-reperfusion injury such as the
heart, skeletal muscle, and visceral organs, in addition to
those such as the lung and the bones/joint that are con-
sidered less vulnerable. The respective chapters emphasize
the pervasive nature of the ischaemia-reperfusion process
and the common pathophysiologic pathways between
seemingly unrelated disciplines. The second section dis-
sects the pathophysiology of ischaemia-reperfusion injury
by examining the various mediators in addition to the
roles of endothelial cells, neutrophils, and apoptosis.
Individual chapters are dedicated to the various mediators,
but they are presented within the context of the whole
ischaemia-reperfusion process. The section underscores
the complexity of the ischaemia-reperfusion process with
its multiple, interrelated, overlapping components.
Indeed, it is not surprising that a “magic bullet” for
ischaemia-reperfusion injury has not been identified in
light of this complexity. The final section integrates the
first two and examines the therapeutic role of free radical
scavengers and antioxidants in addition to the therapies
used to minimize ischaemia-reperfusion injury during car-
diac surgery and solid organ transplantation.
The text provides an excellent review of ischaemia-
reperfusion injury and bridges the gap between the basic
and clinical sciences. The breadth of material presented is
comprehensive and includes all potential mechanisms
incriminated in the process. This is notable in light of the
rapidly evolving discipline and the multiple mediators and
mechanisms. The depth of the presentation is thorough
and sufficient for the basic scientist. The individual chap-
ters consistently review the current clinical and experi-
mental data and summarize our current understanding,
including highlighting the limitations. Indeed, this is par-
ticularly relevant in the chapter (chapter 10) on the clini-
cal relevance of ischaemia-reperfusion in injury in the
bone/joints in which there is little published data.
Although the clinical relevance of ischaemia-reperfusion
injury is emphasized throughout the text, it is not a clini-
cal text per se and should prove useful to the basic scien-
tist. Indeed, the section on the pathophysiology of
ischaemia-reperfusion injury is the strongest of the three.
Critical review of these chapters should allow investigators
to place their research efforts in the necessary perspective
and should generate ideas for further study. The con-
tributing authors are recognized experts in ischaemia-
reperfusion injury and include both clinical and basic sci-
entists. Overall, the quality of the writing is good and
reflects the expertise of the contributors. There is some
variability in the chapters as might be expected from a
multiauthored text, and the variability ranges from super-
ficial to near encyclopedic. The chapter on cytokines
(chapter 20) is disappointing and fails to discuss the
potential role of the anti-inflammatory cytokine inter-
leukin-10. In contrast, the chapters on skeletal muscle
ischaemia-reperfusion injury (chapter 3), endothelial cells
(chapter 15), and nitric oxide (chapter 16) are particular-
ly well written and almost worth the price of the text.
There is a moderate amount of overlap between the
various sections and individual chapters. The inflammato-
ry mediators and cells are reviewed in moderate depth in
all three sections of the text. Admittedly, they are dis-
cussed more superficially in the first and last sections, and
a certain degree of overlap is likely necessary in light of the
complexity of the pathophysiologic process. Additionally,
the chapters on free radical scavengers (chapter 24) and
antioxidants (chapter 26) are similar. The editors stated in
the preface that when they solicited chapters from the var-
ious authors they did not attempt to limit the content.
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This lack of editorial guidance results in a significant
amount of redundancy that limits the overall quality of the
text and makes it difficult to read from cover to cover.
Furthermore, there is a disproportionate emphasis on the
clinical sequelae of cardiac- and transplant-related
ischaemia-reperfusion injury. This may simply reflect the
level of investigation in these disciplines rather than the
bias of the editors or authors. However, the extensive dis-
cussion of hypothermia during cardiac surgery and solid
organ preservation solutions in the final section diverges
slightly from the central theme.
Despite these limitations, the text is a valuable resource
for individuals interested in ischaemia-reperfusion injury.
The editors have achieved their stated objectives of review-
ing the current clinical status of ischaemia-reperfusion
injury, exploring its pathophysiology, and outlining the
treatment strategies. In the process, they have edited a text
that is useful to both clinical and basic scientists.
Thomas Huber, MD
University of Florida
College of Medicine 
Gainesville, Fla
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Since the evolutionary origins of multicellular organ-
isms, stromal cells have inhabited matrix, that is to say,
connective tissue. Accordingly, virtually everything that
happens to us, from normal processes like embryologic
development and wound healing, to pathologic condi-
tions, like tumor invasion and metastasis, is associated with
tissue remodeling. Since the discovery of collagenase
(matrix metalloproteinase–1 = MMP-1) by Lapiere and
Gross in 1962, twenty MMPs have been characterized that
are responsible for many cell/matrix processes. Almost all
of our common diseases, like plaque disruption in athero-
sclerosis, joint destruction in various forms of arthritis,
and loss of alveolar ridge in periodontal disease, involve
MMPs. Presently, there is a dramatic crescendo of interest
in pharmacologic inhibition of MMP activity to alter the
natural history of dozens of diseases.
The present volume of more than 750 pages, pub-
lished as an Annals of the New York Academy of Sciences,
has more than 100 contributions from hundreds of coau-
thors. My “short” review of this compendium is that it is
a must for every scientist working in the MMP field. The
first 100 or so pages provide an authoritative account of
the basic science of MMPs and MMP inhibition, including
molecular models for MMP/inhibitor interactions and
complexities of structure/function relationships. The bal-
ance explores the potential for MMP inhibition in clinical
practice.
My favorite chapter was written by J. Frederick
Woessner, Jr, and is entitled “Matrix Metalloproteinase
Inhibition—From the Jurassic to the Third Millennium.”
He jests that he was invited to speak on this subject, since
he is a living dinosaur in the field, with a living recollec-
tion of the discovery of collagenase. The chapter is a splen-
did overview, with an interesting graphic that illustrates
the exponential growth over time in the rate of discovery
of new MMPs.
Shortly before the symposium in 1998 that gave birth
to this volume, the US Food and Drug Administration
approved doxycycline as an adjunct for periodontal dis-
ease, making it the first agent to be approved for use as a
collagenase inhibitor. I took an interest in the many chap-
ters on doxycycline, because my dentist recently pre-
scribed it to join the battle on my behalf in my own alve-
olar ridge wars. Sorsa and colleagues from Finland report-
ed an office “chairside” dipstick test for monitoring
MMP-8 activity in gingival crevicle fluid. Perhaps someday
we may see a dipstick test on patient serum to monitor
aneurysm inflammation.
There were several chapters relevant to research
endeavors in cardiovascular diseases. R. W. Thompson and
B. T. Baxter coauthored a fine chapter on the rationale for
a prospective, randomized clinical trial of doxycycline as an
inhibitor of aneurysm enlargement, with 83 timely refer-
ences. Loftus and colleagues has two interesting brief
communications. In the first, they reported that MMP
inhibition reduced myointimal hyperplasia in segments of
human saphenous vein cultured in vitro. In the second, in
a study correlating MMP levels in carotid endarterectomy
specimens with clinical symptomatology related to
embolization or plaque rupture, they found evidence for
increased MMP-9 in the group of most symptomatic
plaques.
Up my own alley, there was a chapter on enhanced
MMP expression in the aortas of apolipoprotein E
(apoE)–deficient mice with advanced atherosclerosis.
There have been claims by others that this mouse is a
model of aneurysm formation,1 but the published pho-
tomicrographs suggest that the lesion is a focal false
microaneurysm and not a true fusiform nonspecific
aneurysm with a degenerated adventitia. Also, I have seen
gross photographs of ectatic vessels in this mouse model,
taken in the laboratory of colleagues, and I am suspicious
that some of these ectatic lesions may be poststenotic
dilatations. Anyway, whether the mouse is a valid fusiform
aneurysm model or not, Thompson and Baxter make a
strong case in the previously mentioned chapter of doxy-
cycline in AAA in man.
So, in brief, in the tradition of New York Academy of
Sciences publications, this book defines state-of-the-art,
and I recommend it to all students of connective tissue
diseases.
David Tilson, MD
St Luke–Roosevelt Hospital Center 
New York, NY
